Massachusetts General Hospital
El-Jawahri, Areej, M.D.
The goal of this research study is to determine whether a self-administered, psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT).
Bone Marrow Transplant Complications
Hematologic Malignancy
CARE Application
Usual Care
Not Applicable
This is a randomized clinical trial to determine whether a psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT). The CARE app was developed with the goal of addressing the needs of caregivers of HCT recipients. Participants will be randomized into one of two study groups: CARE app plus Usual Care versus Usual Care. Participation in this study is expected to last up to 100 days after HCT. It is expected that about 120 people will take part in this research study. The Leukemia and Lymphoma Society is supporting this research by providing funding.}}
Study Type : | Interventional |
Estimated Enrollment : | 120 participants |
Masking : | None (Open Label) |
Primary Purpose : | Supportive Care |
Official Title : | Randomized Controlled Trial of a Psychosocial Mobile Application (App) to Promote Coping for Caregivers of Patients Receiving Hematopoietic Cell Transplantation (HCT) |
Actual Study Start Date : | July 1, 2023 |
Estimated Primary Completion Date : | December 1, 2024 |
Estimated Study Completion Date : | December 1, 2025 |
Arm | Intervention/treatment |
---|---|
Experimental: CARE App Participants randomized to the CARE app + usual care will complete the following: Questionnaires at baseline, Day 10, Day 60, and Day 100 post-HCT use the CARE app from enrollment up to 60 days post-HCT: the CARE app includes 5 contains 5 modules and a 6th optional module receive usual care as per HCT practice which entails meeting with a transplant social worker prior to HCT and as needed for extra visits |
Behavioral: CARE Application |
Active Comparator: Usual Care Participants randomized to usual care will complete the following: Questionnaires at baseline, Day 10, Day 60, and Day 100. receive usual care as per HCT practice, which entails meeting with a transplant social worker prior to HCT and as needed for extra visits. |
Behavioral: Usual Care |
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02215